Emory University School of Medicine, Atlanta, Georgia, USA.
Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
Otolaryngol Head Neck Surg. 2019 Dec;161(6):978-985. doi: 10.1177/0194599819865235. Epub 2019 Jul 23.
The Neck Imaging Reporting and Data System (NI-RADS) is a standardized numerical reporting template for surveillance of head and neck squamous cell carcinoma (HNSCC). Our aim was to analyze the accuracy of NI-RADS on the first posttreatment fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography (PET/CECT).
Retrospective cohort study.
Academic tertiary hospital.
Patients with HNSCC with a 12-week posttreatment PET/CECT interpreted using the NI-RADS template and 9 months of clinical and radiologic follow-up starting from treatment completion between June 2014 and July 2016 were included. Treatment failure was defined as positive tumor confirmed by biopsy or Response Evaluation Criteria in Solid Tumors criteria. Cox proportional hazards models were performed.
This study comprised 199 patients followed for a median of 15.5 months after treatment completion (25% quartile, 11.8 months; 75% quartile, 20.2 months). The rates of treatment failure increased with each incremental increase in NI-RADS category from 1 to 3 (4.3%, 9.1%, and 42.1%, respectively). A Cox proportional hazards model demonstrated a strong association between NI-RADS categories and treatment failure at both primary and neck sites (hazard ratio [HR], 2.60 and 5.22, respectively; < .001). In the smaller treatment subgroup analysis, increasing NI-RADS category at the primary site in surgically treated patients and treatment failure did not achieve statistically significant association (HR, 0.88; = .82).
Increasing NI-RADS category at the baseline posttreatment PET/CECT is strongly associated with increased risk of treatment failure in patients with HNSCC.
颈成像报告和数据系统(NI-RADS)是一种用于头颈部鳞状细胞癌(HNSCC)监测的标准化数值报告模板。我们的目的是分析治疗后首次氟脱氧葡萄糖正电子发射断层扫描/对比增强计算机断层扫描(PET/CECT)中 NI-RADS 的准确性。
回顾性队列研究。
学术性三级医院。
纳入 2014 年 6 月至 2016 年 7 月期间治疗后 12 周接受 NI-RADS 模板解读的 HNSCC 患者,以及治疗完成后 9 个月的临床和影像学随访。将肿瘤阳性通过活检或实体瘤反应评估标准证实的定义为治疗失败。进行 Cox 比例风险模型分析。
本研究共纳入 199 例患者,从治疗完成后中位数为 15.5 个月(25%四分位数,11.8 个月;75%四分位数,20.2 个月)进行随访。随着 NI-RADS 类别从 1 级到 3 级的递增,治疗失败的发生率也相应增加(分别为 4.3%、9.1%和 42.1%)。Cox 比例风险模型显示,NI-RADS 类别与原发和颈部部位的治疗失败之间存在很强的关联(风险比[HR]分别为 2.60 和 5.22; <.001)。在较小的治疗亚组分析中,手术治疗患者原发部位的 NI-RADS 类别增加与治疗失败之间未达到统计学显著关联(HR,0.88; =.82)。
治疗后首次 PET/CECT 中 NI-RADS 类别增加与 HNSCC 患者治疗失败的风险增加密切相关。